Subscribe to Money Magazine
CNN/MoneyWeb
Markets & Stocks
graphic
Click here
Stock superstars and wanna-bes
If only you had a time machine, these were the stocks to buy at the start of 2004.
December 29, 2004: 4:31 PM EST

NEW YORK (CNN/Money) - The stock market looks set to chalk up respectable, but not mind-blowing gains for 2004.

Investors in index funds should be satisfied, but maybe just a little bit envious of investors in these 10 companies, which range from high-profile techs (wish you had a bite of that Apple?) to insurers and steelmakers.

Following are the S&P 500 stocks with the biggest year-to-date gains as of Dec. 28.

Autodesk: 214.3 percent -- There's been no slump for this maker of animation and image rendering software. Thanks to a booming construction market, architects and engineers have scooped up Autodesk's products. Analysts are predicting that earnings will more than double in fiscal 2004 and increase 25 percent in 2005.

Apple: 200.3 percent -- Why have shares of Apple nearly tripled this year? One word: iPod. Sales of Apple's popular digital music player surged in 2004, helping Apple to blow away analysts' earnings estimates for the past three quarters. It looks like Apple is no longer just a company for faithful Mac users.

TXU: 175.7 percent -- The energy producer brought in a new CEO in February, and under his guidance, set into a motion a number of moves meant to boost shareholder value.

TXU cut costs and sold off some money-losing divisions. The company also trimmed debt, unveiled two share buyback programs and increased its annual dividend to $2.25 per share from 50 cents (also setting a goal for 5 percent annual dividend growth).

Nucor: 97.9 percent -- The nation's No. 3 steelmaker was helped as finished prices in steel increased faster than prices for steel scrap. That gave Nucor, which produces steel by melting scrap, an advantage over its larger rivals such as U.S. Steel, which still make steel from raw materials.

2004 Year in review Quotes of the year Banned ads

Monsanto: 96.9 percent -- The weak dollar has made this agricultural company's weed-killers, bio-engineered seeds and other agricultural products more price-competitive overseas, boosting international revenue. The company's performance last year wasn't so shabby either – its stock rose 49.5 percent in 2003.

Valero Energy: 92.9 percent -- The nation's largest independent oil refiner was helped by an industrywide improvement in refining profit margins -- unusual during a period of rising oil prices. In 2003, higher oil prices crimped refining margins, and Valero's stock.

Goodyear Tire: 91.0 percent -- The largest U.S. tire maker improved its business in North America by repairing severed ties with many old clients and dealers. After a long spell of red ink in 2002 and 2003, the company turned a profit in the second quarter of 2004 and built on that gain in the third. The stock is trading near 3-year highs.

Starbucks: 90.3 percent -- Will the super-strong coffee ever burn out? The world's No. 1 coffee retailer logged the 13th consecutive year of comparable-store sales increases of at least 5 percent and the stock's jumped 407 percent in the last five years. Sales rose 30% to $5.29 billion with the opening of over a thousand new stores last year. Analysts and company officials still insist the Seattle-based retailer is years away from saturating the market with its latte joints, and accordingly, Starbucks recently increased long-term projected growth from 25,000 to at least 30,000 stores.

Aetna: 86.3 percent -- Cost cutting and underwriting gains have led to strong growth in revenue and earnings; operating income was up 26.6 percent during the first nine months of 2004. Some analysts think the aging U.S. population and Medicare reform can only add to the growth.

Biogen Idec: 84.9 percent -- Investors who bid up shares this year are eyeing good things to come. Tysabri, a blockbuster new drug, hit the market this fall for the treatment of multiple sclerosis, and the company is hoping it will be found effective for treating Crohn's disease. Analysts project that Tysabri, along with Biogen's older MS treatment, Avonex, and its cancer treatment, Rituxin, will drive an eight-fold increase in revenue by 2010.

And the big losers ...
The Worst of 2004
The 10 S&P 500 stocks with the most negative return.*
Company
(Ticker symbol)
Current
price
52-wk
high
52-wk
low
PEG
ratio
YTD
Return*
Teradyne (TER) $8.53 $10.67 $2.80 0.8 -34.9%
Novell (NOVL) $4.19 $4.98 $2.97 1.4 -35.0%
Novellus Systems (NVLS) $21.07 $23.17 $10.26 1.9 -35.1%
Sanmina-Sci (SANM) $8.38 $9.15 $1.13 N/A -35.6%
Delta Airlines (DAL) $7.88 $12.65 $3.51 0.4 -36.1%
LSI Logic (LSI) $5.48 $6.06 $2.36 N/A -39.3%
PMC-Sierra (PMCS) $8.95 $10.07 $2.82 1.6 -46.4%
Ciena (CIEN) $12.40 $16.64 $4.98 14.8 -49.5%
* Through Dec. 28, 2004.
SOURCE: Thomson/First Call
Last updated
Nov 09 16:01

 

 

 

 

 

 

 

 

 

   Top of page




  More on MARKETS
Dow surges to 13-month high
The silence of the bears
Gold continues record run above $1,100
  TODAY'S TOP STORIES
Dow surges to 13-month high
Go the distance - Dividends for the long run
Sprint to slash up to 2,500 jobs




graphic graphic
© 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy
Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.